The fully implanted Acclaim® cochlear implant received Breakthrough Device Designation from the FDA in 2019 and was first implanted in three participants during an early feasibility study (EFS) at ...

The Hong Kong Patent Office granted HK Patent No. HK40097814 to Envoy Medical Corporation on January 3, 2025. The title is Programming of Cochlear Implant Accessories. This patent relates to a system ...

Envoy Medical's Acclaim® Cochlear Implant, a fully implanted device designed ... external components and leverages the ear's natural anatomy to provide continuous hearing. These developments ...

Inc. (NASDAQ: COCH), a small-cap medical device company with a market capitalization of $29.4 million specializing in hearing loss solutions, has announced the expansion of its patent portfolio with ...

Fennec Pharma’s partner Norgine Pharma launches Pedmarqsi in Germany: Monday, February 10, 2025, 14:00 Hrs [IST] Fennec Pharmaceuticals Inc., a specialty pharmaceutical company, ...

Abnormal cochlear anatomy (ie, ossification ... The CI used for the study consists of a Nucleus 7 sound processor and a CI622 implant with a slim straight electrode from Cochlear (or similar). Serial ...

MUSC is leading the country in a clinical trial testing a new cochlear implant.Doctors at MUSC say they are the only site on ...

The Medical University of South Carolina in Charleston will be the first clinical trial site in the country to test a new ...

CHARLESTON, S.C. (WCSC) - The Medical University of South Carolina in Charleston will be the first clinical trial site in the country to test a new cochlear implant for people with hearing loss. The ...